A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*. - Marsteller JA; Sexton JB; Hsu YJ; Hsiao CJ; Holzmueller CG; Pronovost PJ; Thompson DA (Critical Care Medicine, 2012)